Mar 29, 2021 / 08:30PM GMT
Operator
Good afternoon, and welcome to the Wave Life Sciences investor conference call. (Operator Instructions) As a reminder, this call is being recorded and webcast.
I'll now turn the call over to Kate Rausch, Head of Investor Relations at Wave Life Sciences. Please go ahead.
Kate Rausch - Wave Life Sciences Ltd. - Head of IR
Thank you, operator. Good afternoon, and thank you for joining us. With me here today is Dr. Paul Bolno, President and CEO of Wave Life Sciences; and Dr. Mike Panzara, Wave's Chief Medical Officer and Head of Therapeutics Discovery and Development.
This afternoon, we issued a news release announcing results from our PRECISION-HD1 and PRECISION-HD2 core and open-label extension trials. That release can be found in the Investors section of our website at www.wavelifesciences.com, along with a copy of the slides to accompany today's webcast, which will be posted following this call.
Before we begin, I would like to remind you that we'll be making
WAVE Life Sciences Ltd PRECISION-HD Trial Results and Business Update Call Transcript
Mar 30, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers